Market Place
Sourcing Support
Emcure Pharma’s SAKHI Diabetes Program Makes Asia Book of Records
20 Nov 2024 //
INDPHARMAPOST
Emcure Pharmaceuticals launches campaign addressing male anaemia
19 Nov 2024 //
EXPRESSPHARMA
Emcure Pharma posts Q2 FY25 consolidated PAT at Rs. 194.57 Cr
08 Nov 2024 //
INDPHARMAPOST
Emcure Pharma launches stroke awareness campaign with MS Dhoni
08 Nov 2024 //
EXPRESSPHARMA
Emcure Pharma shares climb 6% after strong growth in Q2FY25 results
08 Nov 2024 //
BUSINESS STD
Emcure Pharma Q2 PAT rises 38.2% YoY
08 Nov 2024 //
BUSINESS STD
Emcure Pharma Establishes Emcutix Biopharma for Dermatology
28 Oct 2024 //
#N/A
Emcure Pharma partners with Gilead Sciences to produce HIV drug
04 Oct 2024 //
PRESS RELEASE
Gilead inks licensing deals to boost lenacapivir access
02 Oct 2024 //
FIERCE PHARMA
Emcure Sets Asia Record For Largest Heart-Shaped Structure
01 Oct 2024 //
EXPRESSPHARMA
Emcure Pharmaceuticals launches solution for menopause wellness ‘Arth’ in India
05 Sep 2024 //
INDIANPHARMAPOST
FDC ban exposes fault lines once again
03 Sep 2024 //
EXPRESS PHARMA
After 40% gains from IPO price, new listing Emcure Pharma may see further upside
26 Aug 2024 //
CNBCTV18
Emcure Pharma Promotes Public Breastfeeding For Awareness Week
02 Aug 2024 //
PHARMABIZ
Emcure Pharmaceuticals signs PPA with Sunsure Energy for solar power
26 Jul 2024 //
INDIANPHARMAPOST
Emcure Pharmaceuticals Closes At ?1362.2, Up 0.25% From Previous Day
22 Jul 2024 //
LIVEMINT
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2
05 Jul 2024 //
ECONOMIC TIMES
Emcure Pharma fixes IPO price band at ₹960-₹1,008 a share
28 Jun 2024 //
THE HINDU
Emcure, Gennova settle litigation with HDT, ink pact to develop mRNAvaccines
23 May 2024 //
MONEYCONROL
Emcure to launch the750 mg injectable variant of ferric carboxymaltose
17 May 2023 //
INDIAN PHARMA POST
Emcure seeks to toss billion-dollar lawsuit over Covid vaccine candidate
17 May 2022 //
ENDPTS
Emcure launches EmWocal campaign to raise awareness
10 May 2022 //
ET HEALTH
US firm sues Emcure for $950 million over `stealing` trade secrets
23 Mar 2022 //
TIMESOFINDIA
India Emerges as a Global Leader in Drug Manufacturing
02 Feb 2022 //
THEVOICEOFNATION
Third-wave sweeps through the country - Big pharmas brace up
20 Jan 2022 //
MIDDAY
Gennova to finish Phase 2 & 3 trials of its mRNA jab by January 2022
11 Dec 2021 //
ECONOMICTIMES
Emcure Pharms` Generic Propofol Receives Approval In US
15 Oct 2021 //
FDA
Gennova mRNA-based vaccine awaits nod
28 Sep 2021 //
FINANCIALEXPRESS
Pune-based Gennova to use SII`s Covishield vaccine as the comparator
02 Sep 2021 //
ECONOMICTIMES
Emcure Pharma files DRHP with SEBI
19 Aug 2021 //
PHARMABIZ
NPPA says it cannot calculate price of Emcure’s HIV drug as directed by DoP
09 Aug 2021 //
PHARMABIZ
Aim to take Emcure among top 5 pharma cos: MD
08 Aug 2021 //
ECONOMICTIMES
Emcure Pharma appoints four new directors
28 Jul 2021 //
EXPRESS PHARMA
DoP disposes Emcure Pharma’s review petition against price fixation on darunavir
30 Jun 2021 //
PHARMABIZ
Emcure Pharms` Generic Palonosetron Hydrochloride Receives Approval In US
29 Jun 2021 //
FDA
Cipla, DRL, Emcure, Sun Pharma and Torrent to partner for trial of Molnupiravir
29 Jun 2021 //
EXPRESS PHARMA
Emcure launches generic drug for hyperphosphatemia in chronic kidney disease
02 Jul 2020 //
ECONOMICTIMES
Emcure launches India first generic version of sucroferric oxyhydroxide for CKD
01 Jul 2020 //
EXPRESSPHARMA
What Trends Driving The Adalimumab Biosimilar Market? Global Key Players
19 May 2020 //
OPENPR
Aurobindo Pharma faces class action suit in US for concealing facts
08 Apr 2020 //
BUSINESS-STANDARD
What Driving Adalimumab Biosimilar Market? Top Players Alfred E. Tiefenbacher,
09 Mar 2020 //
OPENPR
DoP rejects Emcure Pharma`s review application against NPPA`s price
23 Jan 2020 //
PHARMABIZ
HC Bars Cipla, 3 others from launching generic version of Bristol-Myer`s Drug
10 Jan 2020 //
THE ECONOMIC TIMES
Emcure Pharms Generic Lurasidone Hydrochloride Receives Approval in US
06 Sep 2019 //
FDA
Indian pharma firms receive 34% of FDA warnings this year
21 Aug 2019 //
DOWNEARTH
Emcure knocked by the FDA for sterility issues after injectable drug recall
15 Aug 2019 //
FIERCE PHARMA
Emcure Pharmaceuticals Receives FDA Warning Letter
14 Aug 2019 //
FDA
Big Pharma`s China growth; Pfizer`s new Upjohn HQ; Hansoh`s $1B Hong Kong IPO
31 May 2019 //
FIERCE PHARMA
Emcure schizophrenia drug recalled after contamination spotted
29 May 2019 //
FIERCE PHARMA
Emcure Pharms Oxybutynin Chloride Receives Approval in US
16 May 2019 //
FDA
Emcure Pharms Oxybutynin Chloride Receives Approval in US
14 May 2019 //
FDA
New legal risks emerge for Indian pharma
20 Apr 2019 //
ECONOMICTIMES
Emcure launches knock-off of Eisai`s cancer drug Halaven at 40% lower price
03 Apr 2019 //
MONEYCONTROL
Pharma sector gets 273 MoUs worth Rs 8,000 crore
21 Jan 2019 //
ECONOMIC TIMES
Enforcement Report - Week of January 16, 2019
16 Jan 2019 //
FDA
Emcure Pharms` Doxycycline Hyclate Receives Approval in US
14 Nov 2018 //
FDA
Emcure Pharms `s Generic Doxycycline Hyclate Receives Approval in US
12 Nov 2018 //
FDA
Enforcement Report - Week of October 31, 2018
31 Oct 2018 //
FDA
Senispar (cinacalcet hydrochloride) : Amgen vs. Emcure Pharmaceuticals
15 Sep 2018 //
PATENT LITIGATION
Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
18 Jul 2018 //
PATENT LITIGATION
